Search Research Articles
Browse Research Categories

Alzheimer’s Peptide Research

Alzheimer’s disease is the most prevalent neurodegenerative disorder worldwide, characterized by progressive cognitive decline, memory loss, amyloid-beta plaque accumulation, tau protein hyperphosphorylation, and neuroinflammation that collectively lead to widespread neuronal loss. Peptide and bioregulator research in this area focuses on multiple therapeutic targets including amyloid clearance, tau stabilization, neuroinflammation reduction, synaptic support, and neuroprotection against disease progression. Compounds including Humanin, Cerebrolysin, Semax, and Epithalon are among those studied for Alzheimer’s-relevant mechanisms. This section of the Cenexa Peptide Research Library covers research on peptides and bioregulators with applications in Alzheimer’s disease and dementia-related neuroscience.

Other Popular Research Categories

Newest Alzheimer’s Research

GHK-Cu and Alzheimer’s Disease Research – Complete Guide

GHK-Cu is a naturally occurring copper-binding tripeptide found in human plasma that declines significantly with age, which has made it a subject of growing interest in Alzheimer's disease research. Scientists studying this compound have found that intranasal GHK-Cu reduced amyloid plaque buildup, lowered brain inflammation, and improved spatial memory performance in genetically engineered mice that develop Alzheimer's-like pathology. The most...

About The Cenexa Labs Research Library

This section of the research library focuses on scientific studies involving and related research. The Cenexa Research Library compiles publicly available scientific literature and research summaries related to peptides, bioregulators, and signaling molecules. Our goal is to make complex scientific research easier to understand without requiring a technical background.
Scroll to Top
0